Santoni M.; Conti A.; Partelli S.; Porta C.; Sternberg C.N.; Procopio G.; Bracarda S.; Basso U.; De Giorgi U.; Derosa L.; Rizzo M.; Ortega C.; Massari F.; Iacovelli R.; Milella M.; Di Lorenzo G.; Buti S.; Cerbone L.; Burattini L.; Montironi R.; Santini D.; Falconi M.; Cascinu S., Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors, «ANNALS OF SURGICAL ONCOLOGY», 2015, 22, pp. 2094 - 2100 [articolo]
Massari F.; Ciccarese C.; Santoni M.; Lopez-Beltran A.; Scarpelli M.; Montironi R.; Cheng L., Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma, «EXPERT REVIEW OF ANTICANCER THERAPY», 2015, 15, pp. 1367 - 1369 [articolo]
Massari F.; Santoni M.; Ciccarese C.; Santini D., The immunocheckpoints in modern oncology: The next 15 years, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2015, 15, pp. 917 - 921 [articolo]
Santoni M.; Piva F.; Scarpelli M.; Cheng L.; Lopez-Beltran A.; Massari F.; Iacovelli R.; Berardi R.; Santini D.; Montironi R., The origin of prostate metastases: emerging insights, «CANCER METASTASIS REVIEWS», 2015, 34, pp. 765 - 773 [articolo]
Massari F.; Ciccarese C.; Santoni M.; Brunelli M.; Conti A.; Modena A.; Montironi R.; Santini D.; Cheng L.; Martignoni G.; Cascinu S.; Tortora G., The route to personalized medicine in bladder cancer: where do we stand?, «TARGETED ONCOLOGY», 2015, 10, pp. 325 - 336 [articolo]
Santoni M.; Conti A.; Massari F.; Arnaldi G.; Iacovelli R.; Rizzo M.; De Giorgi U.; Trementino L.; Procopio G.; Tortora G.; Cascinu S., Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: An up-to-date review and meta-analysis of clinical trials, «INTERNATIONAL JOURNAL OF CANCER», 2015, 136, pp. 1 - 10 [articolo]
Massari F.; Ciccarese C.; Modena A.; Maines F.; Segala D.; Luchini C.; Marcolini L.; Cavicchioli F.; Cavalleri S.; Bria E.; Brunelli M.; Martignoni G.; Artibani W.; Tortora G., Adenocarcinoma of the paraurethral glands: A case report, «HISTOLOGY AND HISTOPATHOLOGY», 2014, 29, pp. 1295 - 1303 [articolo]
Pilotto S.; Bonomi M.; Massari F.; Milella M.; Ciuffreda L.; Brunelli M.; Fassan M.; Chilosi M.; Scarpa A.; Tortora G.; Bria E., Anti-angiogenic drugs and biomarkers in non-small-cell lung cancer: A 'hard days night', «CURRENT PHARMACEUTICAL DESIGN», 2014, 20, pp. 3958 - 3972 [articolo]
Santoni M.; Bracarda S.; Nabissi M.; Massari F.; Conti A.; Bria E.; Tortora G.; Santoni G.; Cascinu S., CXC and CC chemokines as angiogenic modulators in nonhaematological tumors, «BIOMED RESEARCH INTERNATIONAL», 2014, 2014, Article number: 768758, pp. 1 - 12 [articolo]
Santoni M.; Santini D.; Massari F.; Conti A.; Iacovelli R.; Burattini L.; Tortora G.; Falconi M.; Montironi R.; Cascinu S., Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: Suggestions from bench to bedside, «CANCER METASTASIS REVIEWS», 2014, 33, pp. 321 - 331 [articolo]
Fiorini C.; Massari F.; Pedron S.; Sanavio S.; Ciccarese C.; Porcaro A.B.; Artibani W.; Bertoldo F.; Zampini C.; Sava T.; Ficial M.; Calio A.; Chilosi M.; D'Amuri A.; Sanguedolce F.; Tortora G.; Scarpa A.; Delahunt B.; Porta C.; Martignoni G.; Brunelli M., Methods to identify molecular expression of mTOR pathway: A rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors, «AMERICAN JOURNAL OF CANCER RESEARCH», 2014, 4, pp. 907 - 915 [articolo]
Pilotto S.; Di Maio M.; Peretti U.; Kinspergher S.; Brunelli M.; Massari F.; Sperduti I.; Giannarelli D.; De Marinis F.; Tortora G.; Bria E., Predictors of outcome for patients with lung adenocarcinoma carrying the epidermal growth factor receptor mutation receiving 1st-line tyrosine kinase inhibitors: Sensitivity and meta-regression analysis of randomized trials, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2014, 90, pp. 135 - 145 [articolo]
Massari F.; Ciccarese C.; Porcaro A.B.; Ferrero S.; Gazzano G.; Artibani W.; Modena A.; Bria E.; Sava T.; Calio A.; Novara G.; Ficarra V.; Chilosi M.; Martignoni G.; Bosari S.; Cheng L.; Tortora G.; Brunelli M., Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinoma, «PATHOLOGY», 2014, 46, pp. 523 - 526 [articolo]
Bianconi M.; Santoni M.; Massari F.; Faloppi L.; Prete M.D.; Giampieri R.; Ciccarese C.; Modena A.; Tortora G.; Scartozzi M.; Cascinu S., Selected news from the 2014 Genitourinary Cancers Symposium: Translating novel strategies into clinical practice, «FUTURE ONCOLOGY», 2014, 10, pp. 2103 - 2106 [articolo]
Massari F.; Bria E.; Maines F.; Milella M.; Giannarelli D.; Cognetti F.; Pappagallo G.; Tortora G.; Porta C., Adjuvant treatment for resected renal cell carcinoma: Are all strategies equally negative? Potential implications for trial design with targeted agents, «CLINICAL GENITOURINARY CANCER», 2013, 11, pp. 471 - 476 [articolo]
